MANTLE CELL LYMPHOMA RESEARCH INITIATIVE
An Urgent Need
Mantle cell lymphoma (MCL) is a form of non-Hodgkin lymphoma. This rare and aggressive cancer has a median survival of only two to five years, and the 10-year survival rate is between 5 and 10 percent. The cause of MCL is unknown, and the disease remains incurable. But there is hope.
How You Advance Cures
With the support of remarkable donors and The Sarah Cannon Foundation, The Leukemia & Lymphoma Society launched the Mantle Cell Lymphoma Research Initiative, dedicated to advancing novel, bench-to-bedside research dedicated to achieving better treatments for this difficult disease. Through molecular science and emerging breakthrough approaches we believe we can provide significant gains in care. We invite you to join us.
Invest in the Future
Under the Mantle Cell Lymphoma Research Initiative, researchers are exploring combinations of new and existing drugs that work better together than on their own and that focus on killing the cancer cells while leaving healthy cells alone. They are also exploring how to block genes involved in the development of MCL. Perhaps most promising, is the use of immunotherapy and CAR T-cell therapy where the immune cells are engineered to target specific proteins on cancer cells to help them find and kill cancer.
The Power of Your Support
The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. The world’s largest nonprofit organization devoted to blood cancers, LLS has the size and scope to drive research on a scale that makes progress happen. LLS has invested more than $1.2 billion in research since its founding. Last year LLS allocated nearly $35 million of its research budget to aggressive lymphomas like MCL.
LLS has a track record of success in identifying the most promising research, resulting in groundbreaking advances. In fact, LLS played a role in the development of 34 of the unprecedented 40 new blood cancer treatments approved by the FDA since 2017.
Your gift today will bring cures to patients!
For more information about LLS, please visit lls.org